Andrew P. Norgan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrew P. Norgan has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Bobbi S. Pritt
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
9 shared publications - Elizabeth Ann L. Enninga
Department of Obstetrics and Gynecology Mayo Clinic Rochester Minnesota USA
5 shared publications - Burak Tekin
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
4 shared publications - Lori A. Erickson
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
4 shared publications - Ruifeng Guo
Department of Laboratory Medicine and Pathology Mayo Clinic Jacksonville Florida USA
4 shared publications - Sounak Gupta
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4 shared publications
Latest Publications
- Open Access
- 13 February 2025
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 17, 100424
PARAFFIN: A software tool for Pathology Report Automated Feedback for Improved Education of anatomic pathology trainees
- 13 February 2025
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 17, 100424
Open AccessPARAFFIN: A software tool for Pathology Report Automated Feedback for Improved Education of anatomic pathology trainees
- 21 June 2024
- Published by Elsevier in Human Pathology
- Vol. 150, 9-19
High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience
- 21 June 2024
- Published by Elsevier in Human Pathology
- Vol. 150, 9-19
High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience
- 22 May 2024
- Published by Elsevier in Human Pathology
- Vol. 148, 81-86
Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma
- 22 May 2024
- Published by Elsevier in Human Pathology
- Vol. 148, 81-86
Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma
- 14 February 2024
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (2) , e0030823
The Brief Case: Dirofilaria species causing a subcutaneous nodule after a visit to the beach in Florida
- 14 February 2024
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (2) , e0030823
The Brief Case: Dirofilaria species causing a subcutaneous nodule after a visit to the beach in Florida
- Open Access
- 20 December 2023
- Published by American Society for Microbiology in mSphere
- Vol. 8 (6) , e0023223
Genomic epidemiology reveals the dominance of Hennepin County in the transmission of SARS-CoV-2 in Minnesota from 2020 to 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had an unprecedented impact on human health and highlights the need for genomic epidemiology studies to increase our understanding of virus evolution and spread and to inform policy decisions. We sequenced viral genomes from over 22,000 patient samples tested at Mayo Clinic Laboratories between 2020 and 2022 and used Bayesian phylodynamics to describe county and regional spread in Minnesota. The earliest calculated introduction into Minnesota was to Hennepin County from a domestic source around 22 January 2020; 6 weeks before the first confirmed case in the state. This led to the virus spreading to Northern Minnesota and, eventually, the rest of the state. International introductions were most abundant in Hennepin (home to the Minneapolis/St. Paul International Airport) totaling 45 (out of 107) over the 2-year period. Southern Minnesota counties were most common for domestic introductions, with 19 (out of 64), potentially driven by bordering states such as Iowa and Wisconsin as well as Illinois, which is nearby. Hennepin also was, by far, the most dominant source of in-state transmissions to other Minnesota locations ( n = 772) over the 2-year period. We also analyzed the diversity of the location source of SARS-CoV-2 viruses in each county and noted the timing of state-wide policies as well as trends in clinical cases. Neither the number of clinical cases nor the major policy decisions, such as the end of the lockdown period in 2020 or the end of all restrictions in 2021, appeared to have an impact on virus diversity across each individual county. IMPORTANCE: We analyzed over 22,000 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes of patient samples tested at Mayo Clinic Laboratories during a 2-year period in the COVID-19 pandemic, which included Alpha, Delta, and Omicron variants of concern to examine the roles and relationships of Minnesota virus transmission. We found that Hennepin County, the most populous county, drove the transmission of SARS-CoV-2 viruses in the state after including the formation of earlier clades including 20A, 20C, and 20G, as well as variants of concern Alpha and Delta. We also found that Hennepin County was the source for most of the county-to-county introductions after an initial predicted introduction with the virus in early 2020 from an international source, while other counties acted as transmission “sinks.” In addition, major policies, such as the end of the lockdown period in 2020 or the end of all restrictions in 2021, did not appear to have an impact on virus diversity across individual counties.
- 20 December 2023
- Published by American Society for Microbiology in mSphere
- Vol. 8 (6) , e0023223
Open AccessGenomic epidemiology reveals the dominance of Hennepin County in the transmission of SARS-CoV-2 in Minnesota from 2020 to 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had an unprecedented impact on human health and highlights the need for genomic epidemiology studies to increase our understanding of virus evolution and spread and to inform policy decisions. We sequenced viral genomes from over 22,000 patient samples tested at Mayo Clinic Laboratories between 2020 and 2022 and used Bayesian phylodynamics to describe county and regional spread in Minnesota. The earliest calculated introduction into Minnesota was to Hennepin County from a domestic source around 22 January 2020; 6 weeks before the first confirmed case in the state. This led to the virus spreading to Northern Minnesota and, eventually, the rest of the state. International introductions were most abundant in Hennepin (home to the Minneapolis/St. Paul International Airport) totaling 45 (out of 107) over the 2-year period. Southern Minnesota counties were most common for domestic introductions, with 19 (out of 64), potentially driven by bordering states such as Iowa and Wisconsin as well as Illinois, which is nearby. Hennepin also was, by far, the most dominant source of in-state transmissions to other Minnesota locations ( n = 772) over the 2-year period. We also analyzed the diversity of the location source of SARS-CoV-2 viruses in each county and noted the timing of state-wide policies as well as trends in clinical cases. Neither the number of clinical cases nor the major policy decisions, such as the end of the lockdown period in 2020 or the end of all restrictions in 2021, appeared to have an impact on virus diversity across each individual county. IMPORTANCE: We analyzed over 22,000 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes of patient samples tested at Mayo Clinic Laboratories during a 2-year period in the COVID-19 pandemic, which included Alpha, Delta, and Omicron variants of concern to examine the roles and relationships of Minnesota virus transmission. We found that Hennepin County, the most populous county, drove the transmission of SARS-CoV-2 viruses in the state after including the formation of earlier clades including 20A, 20C, and 20G, as well as variants of concern Alpha and Delta. We also found that Hennepin County was the source for most of the county-to-county introductions after an initial predicted introduction with the virus in early 2020 from an international source, while other counties acted as transmission “sinks.” In addition, major policies, such as the end of the lockdown period in 2020 or the end of all restrictions in 2021, did not appear to have an impact on virus diversity across individual counties.
- 19 December 2023
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 161 (5) , 451-462
Detection and quantification of Babesia species intraerythrocytic parasites by flow cytometry
Recent work has demonstrated that automated fluorescence flow cytometry (FLC) is a potential alternative for the detection and quantification of Plasmodium parasites. The objective of this study was to apply this novel FLC method to detect and quantify Babesia parasites in venous blood and compare results to light microscopy and polymerase chain reaction methods. An automated hematology/malaria analyzer (XN-31; Sysmex) was used to detect and quantify B microti–infected red blood cells from residual venous blood samples (n = 250: Babesia positive, n = 170; Babesia negative, n = 80). As no instrument software currently exists for Babesia, qualitative and quantitative machine learning (ML) algorithms were developed to facilitate analysis. Performance of the ML models was verified against the XN-31 software using P falciparum–infected samples. When applied to Babesia-infected samples, the qualitative ML model demonstrated an area under the curve (AUC) of 0.956 (sensitivity, 95.9%; specificity, 83.3%) relative to polymerase chain reaction. For valid scattergrams, the qualitive model achieved an AUC of 1.0 (sensitivity and specificity, 100%), while the quantitative model demonstrated an AUC of 0.986 (sensitivity, 94.4%; specificity, 100%). This investigation demonstrates that Babesia parasites can be detected and quantified directly from venous blood using FLC. Although promising, opportunities remain to improve the general applicability of the method.
- 19 December 2023
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 161 (5) , 451-462
Detection and quantification of Babesia species intraerythrocytic parasites by flow cytometry
Recent work has demonstrated that automated fluorescence flow cytometry (FLC) is a potential alternative for the detection and quantification of Plasmodium parasites. The objective of this study was to apply this novel FLC method to detect and quantify Babesia parasites in venous blood and compare results to light microscopy and polymerase chain reaction methods. An automated hematology/malaria analyzer (XN-31; Sysmex) was used to detect and quantify B microti–infected red blood cells from residual venous blood samples (n = 250: Babesia positive, n = 170; Babesia negative, n = 80). As no instrument software currently exists for Babesia, qualitative and quantitative machine learning (ML) algorithms were developed to facilitate analysis. Performance of the ML models was verified against the XN-31 software using P falciparum–infected samples. When applied to Babesia-infected samples, the qualitative ML model demonstrated an area under the curve (AUC) of 0.956 (sensitivity, 95.9%; specificity, 83.3%) relative to polymerase chain reaction. For valid scattergrams, the qualitive model achieved an AUC of 1.0 (sensitivity and specificity, 100%), while the quantitative model demonstrated an AUC of 0.986 (sensitivity, 94.4%; specificity, 100%). This investigation demonstrates that Babesia parasites can be detected and quantified directly from venous blood using FLC. Although promising, opportunities remain to improve the general applicability of the method.
- 15 November 2023
- Published by Elsevier in Human Pathology
- Vol. 142, 42-50
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma
- 15 November 2023
- Published by Elsevier in Human Pathology
- Vol. 142, 42-50
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma